Suppr超能文献

不同脊椎动物物种大脑β-肾上腺素能受体结合位点的异质性。

Heterogeneity of cerebral beta-adrenoceptor binding sites in various vertebrate species.

作者信息

Nahorski S R

出版信息

Eur J Pharmacol. 1978 Oct 1;51(3):199-209. doi: 10.1016/0014-2999(78)90405-3.

Abstract

[3H]-Dihydroalprenolol ([3H]-DHA) binds to cerebral membranes of the frog, chick, rat, mouse, rabbit and human with a dissociation equilibrium constant (KD) of about 1 nM and displays binding characteristics indicative of an interaction with beta-adrenoceptors. However, the maximum number of specific binding sites labelled by this beta-adrenoceptor ligand varies substantially between the species with the chick and mouse having the highest, and the frog the lowest density. The structure--activity relationships of adrenergic agents to inhibit specific [3H]-DHA binding suggests that whereas the membrane sites from all the species had similar affinities for non-selective beta-adrenergic agents, several drugs that have been reported to show selectivity for beta1-adrenoceptors demonstrated considerably higher affinities for mammalian rather than avian or amphibian membrane sites. By this pharmacological criteria it is likely that all the beta-adrenoceptor binding sites in frog and chick cerebral tissue have properties resembling beta2-receptors. However, in mammalian cerebral cortex, evidence is presented that beta1- and beta2-adrenoceptors coexist in a ratio of 70%/30% respectively.

摘要

[3H]-二氢烯丙洛尔([3H]-DHA)与青蛙、鸡、大鼠、小鼠、兔子和人类的脑膜结合,其解离平衡常数(KD)约为1 nM,并表现出与β-肾上腺素能受体相互作用的结合特性。然而,这种β-肾上腺素能受体配体标记的特异性结合位点的最大数量在不同物种之间有很大差异,其中鸡和小鼠的密度最高,青蛙的密度最低。肾上腺素能药物抑制特异性[3H]-DHA结合的构效关系表明,虽然所有物种的膜位点对非选择性β-肾上腺素能药物具有相似的亲和力,但据报道对β1-肾上腺素能受体具有选择性的几种药物对哺乳动物而非鸟类或两栖动物的膜位点表现出相当高的亲和力。根据这一药理学标准,青蛙和鸡脑组织中的所有β-肾上腺素能受体结合位点可能都具有类似于β2-受体的特性。然而,在哺乳动物大脑皮层中,有证据表明β1-和β2-肾上腺素能受体分别以70%/30%的比例共存。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验